Tsutomu Nakahara Selected Research

Axitinib (AG 013736)

10/2006	Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
2/2006	Effect of inhibition of vascular endothelial growth factor signaling on distribution of extravasated antibodies in tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsutomu Nakahara Research Topics

Disease

27	Ganglion Cysts (Ganglion) 10/2023 - 08/2009
13	Glaucoma 03/2024 - 05/2009
12	Ischemia 10/2023 - 07/2004
12	Retinal Diseases 01/2018 - 05/2009
9	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2024 - 08/2009
8	Cataract (Cataracts) 01/2019 - 01/2008
6	Neoplasms (Cancer) 01/2020 - 02/2006
6	Hypoxia (Hypoxemia) 01/2020 - 01/2011
6	Retinal Degeneration 01/2019 - 11/2010
5	Retinopathy of Prematurity (Retrolental Fibroplasia) 11/2023 - 02/2016
4	Pathologic Neovascularization 01/2024 - 01/2014
4	Diabetes Mellitus 03/2021 - 08/2008
4	Hyperglycemia 01/2019 - 06/2009
4	Inflammation (Inflammations) 12/2018 - 08/2009
4	Reperfusion Injury 08/2015 - 05/2009
4	Fetal Growth Retardation (Intrauterine Growth Retardation) 08/2014 - 01/2010
3	Wounds and Injuries (Trauma) 09/2019 - 08/2009
3	Hyperalgesia 01/2014 - 12/2012
2	Diabetes Complications 01/2023 - 01/2018
2	Premature Birth (Birth, Premature) 08/2021 - 02/2013
2	Vascular Diseases (Vascular Disease) 08/2021 - 05/2015
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2018 - 01/2011
2	Hyperoxia 12/2016 - 10/2015
2	Pre-Eclampsia (Preeclampsia) 03/2014 - 01/2010
2	Neuralgia (Stump Neuralgia) 01/2013 - 12/2012
2	Cystitis 01/2011 - 02/2004
2	Hypertension (High Blood Pressure) 01/2010 - 06/2007
2	Carcinoma (Carcinomatosis) 10/2006 - 02/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2004 - 04/2003
1	Leukemia 01/2024
1	Lymphoma (Lymphomas) 01/2024
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Colitis-Associated Neoplasms 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020

Drug/Important Bio-Agent (IBA)

40	Retinaldehyde (Retinal)IBA 03/2024 - 07/2004
30	N-Methylaspartate (NMDA)IBA 03/2024 - 05/2009
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2006
10	Glutamic Acid (Glutamate)FDA Link 01/2018 - 08/2009
8	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2008
6	Vasodilator Agents (Vasodilators)IBA 08/2021 - 06/2007
6	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2018 - 10/2006
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 05/2009
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2008
4	Drinking WaterIBA 01/2019 - 01/2008
4	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2015 - 06/2009
4	N- (2- chloro- 4- ((6,7- dimethoxy- 4- quinazolinyl)oxy)phenyl)- N'- propylureaIBA 08/2014 - 01/2010
3	Oxygen (Dioxygen)IBA 01/2024 - 01/2014
3	ResveratrolIBA 10/2023 - 09/2011
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2014 - 12/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 12/2012
3	elcatoninIBA 01/2014 - 12/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011 - 02/2004
2	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2020
2	TOR Serine-Threonine KinasesIBA 11/2023 - 01/2014
2	Pyruvaldehyde (Methylglyoxal)IBA 01/2023 - 01/2018
2	ParvalbuminsIBA 04/2021 - 10/2013
2	Probucol (Lorelco)FDA Link 01/2019 - 12/2017
2	SugarsIBA 01/2019 - 04/2008
2	Crystallins (Crystallin)IBA 01/2019 - 01/2018
2	Purinergic P2X7 ReceptorsIBA 12/2018 - 06/2015
2	Neuroprotective AgentsIBA 12/2018 - 05/2009
2	Opioid Receptors (Opioid Receptor)IBA 01/2018 - 10/2017
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2018 - 03/2006
2	Capsaicin (Zostrix)FDA Link 10/2017 - 06/2014
2	Amlodipine (Norvasc)FDA LinkGeneric 10/2015 - 05/2009
2	Everolimus FDA Link 01/2015 - 01/2014
2	Sirolimus (Rapamycin)FDA Link 01/2015 - 01/2014
2	Tyrosine Kinase InhibitorsIBA 08/2014 - 08/2013
2	Messenger RNA (mRNA)IBA 03/2014 - 04/2003
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2013 - 02/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 12/2012
2	GP 1447IBA 01/2012 - 01/2008
2	Aldehyde Reductase (Aldose Reductase)IBA 01/2012 - 01/2008
2	polyolIBA 01/2012 - 01/2010
2	BradykininIBA 09/2011 - 01/2011
2	Donepezil (Aricept)FDA LinkGeneric 01/2010 - 01/2010
2	Axitinib (AG 013736)IBA 10/2006 - 02/2006
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2024
1	Metformin (Glucophage)FDA LinkGeneric 01/2024
1	Bcl-2-Like Protein 11IBA 01/2024
1	mouse MIRN29 microRNAIBA 01/2024
1	Complement System Proteins (Complement)IBA 01/2024
1	Advanced Glycation End ProductsIBA 01/2023
1	malic acid (malate)IBA 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Ouabain (G Strophanthin)IBA 01/2022
1	CitrullineIBA 03/2021
1	Ion Channels (Ion Channel)IBA 01/2020
1	SodiumIBA 01/2020
1	Dextrans (Dextran)FDA Link 01/2020
1	CationsIBA 01/2020
1	Calbindin 2IBA 04/2019
1	AntioxidantsIBA 01/2019

Therapy/Procedure

12	Intravitreal Injections 01/2024 - 01/2013
4	Therapeutics 01/2020 - 02/2006
2	Lenses 01/2012 - 01/2008
2	Aftercare (After-Treatment) 10/2006 - 02/2006